These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38491776)

  • 21. Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
    Prentoe J; Janitzek CM; Velázquez-Moctezuma R; Goksøyr L; Olsen RW; Fanalista M; Augestad EH; Thrane S; Pihl AF; Gottwein JM; Sander AF; Bukh J
    PLoS One; 2021; 16(7):e0255336. PubMed ID: 34329365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of hepatitis C virus envelope proteins with a recombinant baculovirus expression system].
    Tang L; Xu Z; Fu L; Li G; Ren J; Yin W
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):179-82. PubMed ID: 12575178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties.
    Beaumont E; Roch E; Chopin L; Roingeard P
    PLoS One; 2016; 11(3):e0151626. PubMed ID: 26966906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous Quantification of Hepatitis C Virus Envelope Glycoproteins E1 and E2 by Dual-Color Fluorescence Immunoblot Analysis.
    Chen F; Giang E; Gopal R; Law M
    Methods Mol Biol; 2019; 1911():295-304. PubMed ID: 30593634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.
    Freedman H; Logan MR; Hockman D; Koehler Leman J; Law JLM; Houghton M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.
    Lesniewski RR; Watanabe S; Devare SG
    Princess Takamatsu Symp; 1995; 25():129-37. PubMed ID: 8875617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses.
    Seong YR; Choi S; Lim JS; Lee CH; Lee CK; Im DS
    Vaccine; 2001 Apr; 19(20-22):2955-64. PubMed ID: 11282207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.
    Ralston R; Thudium K; Berger K; Kuo C; Gervase B; Hall J; Selby M; Kuo G; Houghton M; Choo QL
    J Virol; 1993 Nov; 67(11):6753-61. PubMed ID: 8411378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells.
    Hüssy P; Schmid G; Mous J; Jacobsen H
    Virus Res; 1996 Nov; 45(1):45-57. PubMed ID: 8896240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease.
    Hada H; Koide N; Hanafusa T; Sakaguchi K; Shinji T; Sasaki S; Oka T; Takayama N; Yumoto Y; Tsuji T
    Acta Med Okayama; 1992 Oct; 46(5):365-70. PubMed ID: 1279946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
    Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
    J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of apolipoprotein E into HBV-HCV subviral envelope particles to improve the hepatitis vaccine strategy.
    Gomez-Escobar E; Burlaud-Gaillard J; Visdeloup C; Ribeiro E Silva A; Coutant P; Roingeard P; Beaumont E
    Sci Rep; 2021 Nov; 11(1):21856. PubMed ID: 34750487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of antibody against hepatitis C virus first envelope (HCV-E1) protein and its clinical application].
    Xu J; Ye L; Gao J; Zhang B; Ruan H; Wu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):392-4. PubMed ID: 12665917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine antibody against E2 can capture hepatitis C virus in vitro.
    Ma W; Feng B; Tao Q
    Chin Med J (Engl); 2001 Aug; 114(8):860-3. PubMed ID: 11780368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
    Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
    Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.